Mirtazapine use may increase the risk of hypothyroxinemia in patients affected by major depressive disorder
نویسندگان
چکیده
منابع مشابه
The effects of mirtazapine on sleep in patients with major depressive disorder.
BACKGROUND Mirtazapine is a commonly used antidepressant with a well-known ability to produce sedation. At the same time, its sleep-promoting effects in patients with major depressive disorder (MDD) are relatively unclear. The purpose of this article is to provide clinicians with a detailed review of mirtazapine's sleep effects in patients with MDD. METHODS A literature search was conducted f...
متن کاملIdentifying Early Maladaptive Schema of Patients with Major Depressive Disorder
Cognitive models of depression propose that negative schemas and Early Maladaptive Schema contribute to depressive symptoms. The purpose of this study is to identify the early maladaptive Schema of patients with depression disorder. The method of study is descriptive. Research statistics involves all patients with depression disorder who have come to the c...
متن کاملIdentifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
BACKGROUND Mirtazapine, which is classified as a noradrenergic and specific serotonergic antidepressant, is widely prescribed for the treatment of major depressive disorder. The potential predictive factors of the efficacy of mirtazapine and the tolerability based on the incidence of oversedation and jitteriness/anxiety syndrome were evaluated. PATIENTS AND METHODS Patients with major depress...
متن کاملCorrelation of HbA1c and Major Depressive Disorder in Type 2 Diabetic Patients
OBJECTIVE: To evaluate the relation between major depressions and glucose control index in type 2 diabetes mellitus. MATERIALS AND METHODS: One- hundred thirty four patients with type 2 diabetes were enrolled in this study. Hamilton Rating Scale for Depression (HAM-D) and HbA1c were measured in patients. Linear mixed-model analysis was applied to determine the relation between HbA1c levels and...
متن کاملComorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional Study
Background: Mood disorders are the most common psychiatric comorbidities in substance users. Mood disorders and substance use disorders are 2 intertwined processes in which treating one aid in treating the other. Depression and substance use disorder are now regarded as major mental health issues due to their widespread incidence. The study was designed to investigate the prevalence of major ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2021
ISSN: 0306-5251,1365-2125
DOI: 10.1111/bcp.14949